| Bioactivity | Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention. |
| Name | Bendazac L-Lysine |
| CAS | 81919-14-4 |
| Formula | C22H28N4O5 |
| Molar Mass | 428.48 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Yin XX, et al. Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats. |
Bendazac L-Lysine
CAS: 81919-14-4 F: C22H28N4O5 W: 428.48
Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vi
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.